Kay Noel
Virginia Tech(US)
Publications by Year
Research Areas
Galectins and Cancer Biology, Protein Degradation and Inhibitors, Glycosylation and Glycoproteins Research, RNA modifications and cancer, Cancer-related gene regulation
Most-Cited Works
- → Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease(2017)7,155 cited
- → Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis(2007)322 cited
- → OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models(2016)150 cited
- → OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations(2016)58 cited
- → Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib(2013)39 cited
- → Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models(2019)12 cited
- → CuATSM Phase 2a Study Confirms Disease-Modifying Effects in Patients with Sporadic ALS Observed in the Phase 1 Study (1338)(2020)10 cited
- → Abstract LB-108: A potent and selective small molecule degrader of STAT5 for the treatment of hematological malignancies(2020)9 cited
- → [P‐165]: DHA and cognitive function in the elderly: A systematic review of the literature(2005)6 cited
- → The Brd-Inhibitor OTX015 Is Active in Pre-Clinical Models of Mature B-Cell Lymphoid Tumors(2012)4 cited